Meanwhile, studies have shown that FLZ, a novel phosphamide derivative, can improve the inflammatory state of the brain in PD mouse models by inhibiting TLR4/MyD88/NF-κB signaling pathway (Zhao et al., 2021a). The gene discussed is TLR4; the disease is Parkinson disease.